These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 12424713

  • 1. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.
    Jain AB, Eghtesad B, Venkataramanan R, Fontes PA, Kashyap R, Dvorchik I, Shakil AO, Kingery L, Fung JJ.
    Liver Transpl; 2002 Nov; 8(11):1007-13. PubMed ID: 12424713
    [Abstract] [Full Text] [Related]

  • 2. Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection.
    Jain A, Vekatramanan R, Yelochan B, Kashyap R, Marcos A, Fung J.
    Transplant Proc; 2005 Sep; 37(7):3190-6. PubMed ID: 16213346
    [Abstract] [Full Text] [Related]

  • 3. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C.
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [Abstract] [Full Text] [Related]

  • 4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Aug; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J.
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [Abstract] [Full Text] [Related]

  • 6. [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].
    Kamar N, Sandres-Saune K, Selves J, Durand D, Izopet J, Rostaing L.
    Nephrologie; 2003 Nov; 24(2):89-94. PubMed ID: 12723514
    [Abstract] [Full Text] [Related]

  • 7. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra E, Kullak-Ublick GA, Keller W, Fried R, Vanlemmens C, Kraehenbuhl S, Locher S, Egger HP, Clavien PA, Hadengue A, Mentha G, Morel P, Negro F.
    Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
    [Abstract] [Full Text] [Related]

  • 8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 9. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.
    Transplant Proc; 2004 Feb; 36(6):1831-4. PubMed ID: 15350490
    [Abstract] [Full Text] [Related]

  • 10. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
    Gane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, Williams R.
    Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 12. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
    Sulkowski MS, Wasserman R, Brooks L, Ball L, Gish R.
    J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
    [Abstract] [Full Text] [Related]

  • 13. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 14. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N, Ribes D, Izopet J, Rostaing L.
    Transplantation; 2006 Oct 15; 82(7):853-6. PubMed ID: 17038897
    [Abstract] [Full Text] [Related]

  • 15. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
    Burra P, Targhetta S, Pevere S, Boninsegna S, Guido M, Canova D, Brolese A, Masier A, D'Aloiso C, Germani G, Tomat S, Fagiuoli S.
    Transplant Proc; 2006 May 15; 38(4):1127-30. PubMed ID: 16757285
    [Abstract] [Full Text] [Related]

  • 16. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH, He Y, Yang X, Gong GZ, Zhou HY, Zhang CY, Zhou W, Huang L, Ding PP, Li H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 15; 13(10):741-4. PubMed ID: 16248945
    [Abstract] [Full Text] [Related]

  • 17. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep 15; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
    Calanca LN, Fehr T, Jochum W, Fischer-Vetter J, Müllhaupt B, Wüthrich RP, Ambühl PM.
    J Clin Virol; 2007 May 15; 39(1):54-8. PubMed ID: 17409018
    [Abstract] [Full Text] [Related]

  • 19. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC.
    Arthritis Rheum; 2002 Dec 15; 46(12):3317-26. PubMed ID: 12483738
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
    Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT.
    Liver Transpl; 2003 Nov 15; 9(11):1159-65. PubMed ID: 14586876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.